Product Information
GNP PINK BISMUTH 262 MG TB CHW is a generic product labeled by AmerisourceBergen, priced at $0.0817 per EA under NDC 46122070165. Its NADAC has been published 208 times since Oct 12, 2022.
Strength
262 mg/1
Manufacturer
AmerisourceBergenNDC
46122070165
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BISMUTH SUBSALICYLATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M002On Market Since
9/16/2021
Price Statistics
The NADAC for GNP PINK BISMUTH 262 MG TB CHW has been published 208 times since Oct 12, 2022, and over the history we have for it it has risen 3.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0817 per EA |
|---|---|
| All-time high | $0.0854 (Dec 10, 2025) |
| All-time low | $0.0690 (Sep 20, 2023) |
| 52-week high | $0.0854 |
| 52-week low | $0.0809 |
| Median price | $0.0795 |
| Average price | $0.0785 |
| Largest weekly change | +12.5% (Aug 21, 2024) |
| Weeks tracked | 208 |
| Tracking since | Oct 12, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bismuth subsalicylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP PINK BISMUTH 262 MG TB CHW?
The current National Average Drug Acquisition Cost (NADAC) for GNP PINK BISMUTH 262 MG TB CHW, manufactured by AmerisourceBergen, is $0.0817 per EA (NDC 46122070165), effective Sep 30, 2026.
How has the price of GNP PINK BISMUTH 262 MG TB CHW changed over time?
Over the history we have for it, the NADAC for GNP PINK BISMUTH 262 MG TB CHW has risen 3.7%. It has been tracked across 208 weekly CMS publications since Oct 12, 2022.
What are the highest and lowest recorded NADAC prices for GNP PINK BISMUTH 262 MG TB CHW?
Since Oct 12, 2022, the NADAC for GNP PINK BISMUTH 262 MG TB CHW has ranged from a low of $0.0690 (Sep 20, 2023) to a high of $0.0854 (Dec 10, 2025), with a median of $0.0795 per EA.
Are there cheaper alternatives to GNP PINK BISMUTH 262 MG TB CHW?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GNP PINK BISMUTH 262 MG TB CHW in a comparable dosage form, but none are currently priced below it.
Who manufactures GNP PINK BISMUTH 262 MG TB CHW?
GNP PINK BISMUTH 262 MG TB CHW (NDC 46122070165) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.